S&P 500   4,303.18 (+0.14%)
DOW   34,137.68 (+0.66%)
QQQ   331.06 (-0.60%)
AAPL   172.35 (-0.49%)
MSFT   292.07 (-0.48%)
META   178.83 (-1.14%)
GOOGL   121.32 (-0.62%)
AMZN   144.29 (+0.78%)
TSLA   917.32 (-1.15%)
NVDA   188.36 (-1.03%)
NIO   20.81 (-2.30%)
BABA   92.52 (-1.78%)
AMD   99.88 (-1.12%)
MU   63.61 (-1.68%)
T   18.60 (+1.14%)
CGC   3.78 (-1.05%)
F   16.42 (+0.61%)
GE   80.76 (+1.19%)
DIS   125.14 (+0.71%)
AMC   24.80 (+2.44%)
PYPL   102.08 (+0.56%)
PFE   49.78 (+0.06%)
NFLX   246.18 (-1.18%)
S&P 500   4,303.18 (+0.14%)
DOW   34,137.68 (+0.66%)
QQQ   331.06 (-0.60%)
AAPL   172.35 (-0.49%)
MSFT   292.07 (-0.48%)
META   178.83 (-1.14%)
GOOGL   121.32 (-0.62%)
AMZN   144.29 (+0.78%)
TSLA   917.32 (-1.15%)
NVDA   188.36 (-1.03%)
NIO   20.81 (-2.30%)
BABA   92.52 (-1.78%)
AMD   99.88 (-1.12%)
MU   63.61 (-1.68%)
T   18.60 (+1.14%)
CGC   3.78 (-1.05%)
F   16.42 (+0.61%)
GE   80.76 (+1.19%)
DIS   125.14 (+0.71%)
AMC   24.80 (+2.44%)
PYPL   102.08 (+0.56%)
PFE   49.78 (+0.06%)
NFLX   246.18 (-1.18%)
S&P 500   4,303.18 (+0.14%)
DOW   34,137.68 (+0.66%)
QQQ   331.06 (-0.60%)
AAPL   172.35 (-0.49%)
MSFT   292.07 (-0.48%)
META   178.83 (-1.14%)
GOOGL   121.32 (-0.62%)
AMZN   144.29 (+0.78%)
TSLA   917.32 (-1.15%)
NVDA   188.36 (-1.03%)
NIO   20.81 (-2.30%)
BABA   92.52 (-1.78%)
AMD   99.88 (-1.12%)
MU   63.61 (-1.68%)
T   18.60 (+1.14%)
CGC   3.78 (-1.05%)
F   16.42 (+0.61%)
GE   80.76 (+1.19%)
DIS   125.14 (+0.71%)
AMC   24.80 (+2.44%)
PYPL   102.08 (+0.56%)
PFE   49.78 (+0.06%)
NFLX   246.18 (-1.18%)
S&P 500   4,303.18 (+0.14%)
DOW   34,137.68 (+0.66%)
QQQ   331.06 (-0.60%)
AAPL   172.35 (-0.49%)
MSFT   292.07 (-0.48%)
META   178.83 (-1.14%)
GOOGL   121.32 (-0.62%)
AMZN   144.29 (+0.78%)
TSLA   917.32 (-1.15%)
NVDA   188.36 (-1.03%)
NIO   20.81 (-2.30%)
BABA   92.52 (-1.78%)
AMD   99.88 (-1.12%)
MU   63.61 (-1.68%)
T   18.60 (+1.14%)
CGC   3.78 (-1.05%)
F   16.42 (+0.61%)
GE   80.76 (+1.19%)
DIS   125.14 (+0.71%)
AMC   24.80 (+2.44%)
PYPL   102.08 (+0.56%)
PFE   49.78 (+0.06%)
NFLX   246.18 (-1.18%)
NASDAQ:STRM

Streamline Health Solutions - STRM Stock Forecast, Price & News

$1.66
-0.01 (-0.60%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.64
$1.67
50-Day Range
$1.05
$1.70
52-Week Range
$1.04
$1.88
Volume
3,871 shs
Average Volume
28,997 shs
Market Capitalization
$81.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

Streamline Health Solutions MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
80.7% Upside
$3.00 Price Target
Short Interest
Healthy
0.29% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.17mentions of Streamline Health Solutions in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.16 out of 5 stars

Medical Sector

602nd out of 1,124 stocks

Computer Integrated Systems Design Industry

18th out of 40 stocks

STRM stock logo

About Streamline Health Solutions (NASDAQ:STRM) Stock

Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. It provides computer software-based solutions, professional consulting, and auditing and coding services, which capture, aggregate, and translate structured and unstructured data to deliver predictive insights. The company also offers coding and clinical documentation improvement (CDI) solutions, which include an integrated cloud-based software suite, CDI, and abstracting and physician query; and eValuator, a coding analysis platform, as well as software services. In addition, it provides financial management solutions, including accounts receivable management, denials management, claims processing, spend management, and audit management; patient care solutions; Cerner Command Language (CCL) reporting; and custom integration services for CDI/abstracting, training, and audit services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on STRM shares. Lake Street Capital started coverage on shares of Streamline Health Solutions in a research note on Friday, May 20th. They issued a "buy" rating and a $3.00 target price on the stock. StockNews.com assumed coverage on shares of Streamline Health Solutions in a report on Tuesday, August 9th. They set a "sell" rating for the company. Finally, TheStreet cut shares of Streamline Health Solutions from a "c-" rating to a "d+" rating in a report on Friday, June 10th.

Streamline Health Solutions Price Performance

STRM opened at $1.66 on Tuesday. The company has a debt-to-equity ratio of 0.30, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a 50 day moving average price of $1.40 and a 200-day moving average price of $1.41. Streamline Health Solutions has a twelve month low of $1.04 and a twelve month high of $1.88.

Streamline Health Solutions (NASDAQ:STRM - Get Rating) last released its quarterly earnings data on Wednesday, June 8th. The company reported ($0.06) earnings per share for the quarter. Streamline Health Solutions had a negative net margin of 35.29% and a negative return on equity of 22.28%. The company had revenue of $5.94 million for the quarter.

Receive STRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Streamline Health Solutions and its competitors with MarketBeat's FREE daily newsletter.

STRM Stock News Headlines

Copper More Critical than Lithium?
Lithium may have grabbed the headlines as a key material in building electric vehicles (EVs). But so is copper. And copper's importance in the new green economy goes far beyond EVs. Copper is critical in building wind turbines and solar panels. It's key to power lines and upgrading the national grid. Analysts say we're facing a 10-million-ton shortfall if new copper mines are not found.
Copper More Critical than Lithium?
Lithium may have grabbed the headlines as a key material in building electric vehicles (EVs). But so is copper. And copper's importance in the new green economy goes far beyond EVs. Copper is critical in building wind turbines and solar panels. It's key to power lines and upgrading the national grid. Analysts say we're facing a 10-million-ton shortfall if new copper mines are not found.
Avelead Announces Expansion of Leadership Team
Here's what to expect from Streamline Health Solutions's earnings report
Earnings Outlook For Streamline Health Solns
See More Headlines
Receive STRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Streamline Health Solutions and its competitors with MarketBeat's FREE daily newsletter.

STRM Company Calendar

Last Earnings
6/08/2022
Today
8/16/2022
Next Earnings (Estimated)
9/14/2022
Fiscal Year End
1/31/2023

Industry, Sector and Symbol

Industry
Computer integrated systems design
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:STRM
Fax
N/A
Employees
66
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.00
High Stock Price Forecast
$3.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+80.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-6,540,000.00
Pretax Margin
-35.02%

Debt

Sales & Book Value

Annual Sales
$17.38 million
Book Value
$0.72 per share

Miscellaneous

Free Float
35,473,000
Market Cap
$81.04 million
Optionable
Not Optionable
Beta
0.80

Key Executives

  • Mr. Wyche T. Green III (Age 50)
    Chairman, Pres & CEO
    Comp: $710.7k
  • Mr. Thomas J. Gibson (Age 58)
    Sr. VP, CFO & Principal Accounting Officer
    Comp: $421.37k
  • Jacob Goldberger
    Director of Investor Relations and FP&A
  • Wendy Lucio
    Chief People Officer
  • Mr. Ben Stilwill
    Pres & CEO of eValuator Solutions
  • Lance Seach
    Sr. VP of Bus. Devel.
  • Ms. Amy Sebero
    Chief Growth Officer of eValuator Solutions
  • Jawad Shaikh
    Pres & CEO of Avelead
  • Mr. Donald E. Vick Jr. (Age 58)
    Director of Sales & Operations Analytics













STRM Stock - Frequently Asked Questions

Should I buy or sell Streamline Health Solutions stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Streamline Health Solutions in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" STRM shares.
View STRM analyst ratings
or view top-rated stocks.

What is Streamline Health Solutions' stock price forecast for 2022?

2 brokerages have issued 1-year price objectives for Streamline Health Solutions' stock. Their STRM share price forecasts range from $3.00 to $3.00. On average, they expect the company's stock price to reach $3.00 in the next year. This suggests a possible upside of 80.7% from the stock's current price.
View analysts price targets for STRM
or view top-rated stocks among Wall Street analysts.

How have STRM shares performed in 2022?

Streamline Health Solutions' stock was trading at $1.49 at the beginning of 2022. Since then, STRM stock has increased by 11.4% and is now trading at $1.66.
View the best growth stocks for 2022 here
.

When is Streamline Health Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, September 14th 2022.
View our STRM earnings forecast
.

How were Streamline Health Solutions' earnings last quarter?

Streamline Health Solutions, Inc. (NASDAQ:STRM) announced its quarterly earnings data on Wednesday, June, 8th. The company reported ($0.06) EPS for the quarter. The company earned $5.94 million during the quarter. Streamline Health Solutions had a negative net margin of 35.29% and a negative trailing twelve-month return on equity of 22.28%.

What is David Sides' approval rating as Streamline Health Solutions' CEO?

31 employees have rated Streamline Health Solutions Chief Executive Officer David Sides on Glassdoor.com. David Sides has an approval rating of 82% among the company's employees.

What other stocks do shareholders of Streamline Health Solutions own?
What is Streamline Health Solutions' stock symbol?

Streamline Health Solutions trades on the NASDAQ under the ticker symbol "STRM."

Who are Streamline Health Solutions' major shareholders?

Streamline Health Solutions' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include David Driscoll, Global Healthcare Fun Tamarack, Kenan Lucas and Wyche T Green III.
View institutional ownership trends
.

How do I buy shares of Streamline Health Solutions?

Shares of STRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Streamline Health Solutions' stock price today?

One share of STRM stock can currently be purchased for approximately $1.66.

How much money does Streamline Health Solutions make?

Streamline Health Solutions (NASDAQ:STRM) has a market capitalization of $81.04 million and generates $17.38 million in revenue each year. The company earns $-6,540,000.00 in net income (profit) each year or ($0.16) on an earnings per share basis.

How can I contact Streamline Health Solutions?

Streamline Health Solutions' mailing address is 11800 AMBER PARK DRIVE - SUITE 125, ALPHARETTA GA, 30009. The official website for the company is www.streamlinehealth.net. The company can be reached via phone at (888) 997-8732 or via email at randy.salisbury@streamlinehealth.net.

This page (NASDAQ:STRM) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.